Suramin in Treating Patients With Recurrent Bladder Cancer
A Phase I Study of Intravesicular Suramin in Recurrent Superficial Bladder Cancer
Sponsor: Cancer Research UK
Listed as NCT00006476, this PHASE1 trial focuses on Bladder Cancer and remains completed. Sponsored by Cancer Research UK, it has been updated 5 times since 2000, reflecting limited change activity. This study contributes to the evolving evidence base for cancer treatment protocols.
Change History
5 versions recorded-
Sep 2024 — Present [monthly]
Completed PHASE1
-
Jul 2024 — Sep 2024 [monthly]
Completed PHASE1
-
Jan 2021 — Jul 2024 [monthly]
Completed PHASE1
-
Jun 2018 — Jan 2021 [monthly]
Completed PHASE1
-
Jan 2017 — Jun 2018 [monthly]
Completed PHASE1
First recorded
Oct 2000
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Cancer Research UK
For direct contact, visit the study record on ClinicalTrials.gov .
Study Locations
- • Oxford, United Kingdom